Return On Equity of Organogenesis Holdings Inc. from 30 Jun 2017 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Organogenesis Holdings Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2017 to 31 Dec 2025.
  • Organogenesis Holdings Inc. Return On Equity for the quarter ending 31 Dec 2025 was 14%, a 4416% increase year-over-year.
  • Organogenesis Holdings Inc. annual Return On Equity for 2025 was 14%, a 4416% increase from 2024.
  • Organogenesis Holdings Inc. annual Return On Equity for 2024 was 0.32%, a 82% decline from 2023.
  • Organogenesis Holdings Inc. annual Return On Equity for 2023 was 1.8%, a 70% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Organogenesis Holdings Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 14% +14% +4416% 01 Oct 2025 31 Dec 2025
Q3 2025 0.4% +3.1% 01 Jul 2025 30 Sep 2025
Q2 2025 -3.2% +2.8% +46% 01 Apr 2025 30 Jun 2025
Q1 2025 -6.1% -8.2% -388% 01 Jan 2025 31 Mar 2025
Q4 2024 0.32% -1.5% -82% 01 Oct 2024 31 Dec 2024
Q3 2024 -2.7% -7.5% -156% 01 Jul 2024 30 Sep 2024
Q2 2024 -6% -9.8% -259% 01 Apr 2024 30 Jun 2024
Q1 2024 2.1% -3.1% -59% 01 Jan 2024 31 Mar 2024
Q4 2023 1.8% -4.3% -70% 01 Oct 2023 31 Dec 2023
Q3 2023 4.8% -19% -80% 01 Jul 2023 30 Sep 2023
Q2 2023 3.8% -27% -88% 01 Apr 2023 30 Jun 2023
Q1 2023 5.2% -34% -87% 01 Jan 2023 31 Mar 2023
Q4 2022 6.1% -44% -88% 01 Oct 2022 31 Dec 2022
Q3 2022 24% -13% -36% 01 Jul 2022 30 Sep 2022
Q2 2022 31% -21% -41% 01 Apr 2022 30 Jun 2022
Q1 2022 39% -5.5% -12% 01 Jan 2022 31 Mar 2022
Q4 2021 50% +25% +98% 01 Oct 2021 31 Dec 2021
Q3 2021 37% +44% 01 Jul 2021 30 Sep 2021
Q2 2021 52% +154% 01 Apr 2021 30 Jun 2021
Q1 2021 45% +168% 01 Jan 2021 31 Mar 2021
Q4 2020 25% +153% 01 Oct 2020 31 Dec 2020
Q3 2020 -7.3% +160% +96% 01 Jul 2020 30 Sep 2020
Q2 2020 -102% +165% +62% 01 Apr 2020 30 Jun 2020
Q1 2020 -123% -2729% -105% 01 Jan 2020 31 Mar 2020
Q4 2019 -128% -457% -139% 01 Oct 2019 31 Dec 2019
Q3 2019 -167% -346% -193% 01 Jul 2019 30 Sep 2019
Q2 2019 -267% -466% -234% 01 Apr 2019 30 Jun 2019
Q1 2019 2606% +2304% +763% 01 Jan 2019 31 Mar 2019
Q4 2018 329% -9167% -97% 01 Oct 2018 31 Dec 2018
Q3 2018 179% -1159% -87% 01 Jul 2018 30 Sep 2018
Q2 2018 199% +340% 01 Apr 2018 30 Jun 2018
Q1 2018 302% 01 Jan 2018 31 Mar 2018
Q4 2017 9496% 01 Oct 2017 31 Dec 2017
Q3 2017 1338% 01 Jul 2017 30 Sep 2017
Q2 2017 -141% 01 Apr 2017 30 Jun 2017

Organogenesis Holdings Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 14% +14% +4416% 01 Jan 2025 31 Dec 2025
2024 0.32% -1.5% -82% 01 Jan 2024 31 Dec 2024
2023 1.8% -4.3% -70% 01 Jan 2023 31 Dec 2023
2022 6.1% -44% -88% 01 Jan 2022 31 Dec 2022
2021 50% +25% +98% 01 Jan 2021 31 Dec 2021
2020 25% +153% 01 Jan 2020 31 Dec 2020
2019 -128% -457% -139% 01 Jan 2019 31 Dec 2019
2018 329% -10256% -97% 01 Jan 2018 31 Dec 2018
2017 10585% 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.